Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects

Journal of Neuroscience

Volumn 34, Issue 10, 2014, Pages 3545-3558

  Moreno, Estefanía ^a   Moreno Delgado, David ^a   Navarro, Gemma ^a   Hoffmann, Hanne M ^b   Fuentes, Silvia ^b   Rosell Vilar, Santi ^b   Gasperini, Paola ^a   Rodríguez Ruiz, Mar ^a   Medrano, Mireia ^a   Mallol, Josefa ^a   Cortés, Antoni ^a   Casadó, Vicent ^a   Lluís, Carme ^a   Ferré, Sergi ^c   Ortiz, Jordi ^b   Canela, Enric ^a   McCormick, Peter J ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; COCAINE; DOPAMINE 1 RECEPTOR; HISTAMINE H3 RECEPTOR; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RADIOLIGAND; SIGMA 1 OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; ASSAY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL CULTURE; CELL DEATH; CELL SIGNALING ASSAY; CONTROLLED STUDY; CORPUS STRIATUM; EX VIVO STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING ASSAY; RNA EXTRACTION; SEQUENTIAL RESONANCE ENERGY TRANSFER ASSAY; TRANSIENT TRANSFECTION;

ANIMALS; BENZAMIDES; BENZAZEPINES; CELL LINE, TUMOR; COCAINE; CORPUS STRIATUM; DRUG DELIVERY SYSTEMS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, HISTAMINE H3; RECEPTORS, SIGMA; SIGNAL TRANSDUCTION;

EID: 84895488459     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4147-13.2014     Document Type: Article

References (53)

1. Aksenov M. Y, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27:217-228. CrossRef Medline
2. Arias-Montaño JA, Floran B, Garcia M, Aceves J, Young JM (2001) Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutyric acid from rat striatal slices. Br J Pharmacol 133:165-171. CrossRef Medline
3. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Hervé D, Valjent E, Girault JA (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671-5685. CrossRef Medline
4. Carriba P., Navarro G, Ciruela F, Ferré S, Casadó V, Agnati L, Cortés A, Mallol J, Fuxe K, Canela EI, Lluís C, Franco R (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5:727-733. CrossRef Medline
5. Casadó V., Cortés A, Ciruela F, Mallol J, Ferré S, Lluis C, Canela EI, Franco R (2007) Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. Pharmacol Ther 116: 343-354. CrossRef Medline
6. Cui G., Jun SB, Jin X, Pham MD, Vogel SS, Lovinger DM, Costa RM (2013) Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494:238-242. CrossRef Medline
7. Cunha-Oliveira T, Rego AC, Oliveira CR (2008) Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 58:192-208. CrossRef Medline
8. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) β-Arrestins and Cell Signaling. Annu Rev Physiol 69:483-510. CrossRef Medline
9. Ellenbroek B. A (2013) Histamine H3 receptors, the complex interaction with dopamine and its implications for addiction. Br J Pharmacol 170: 46-57. CrossRef Medline
10. Ferrada C., Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R., Ferré S, Lluís C, Franco R (2009) Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol 157:64-75. CrossRef Medline
11. Ferré S., Agnati LF, Ciruela F, Lluis C, Woods AS, Fuxe K, Franco R (2007) Neurotransmitter receptor heteromers and their integrative role in "local modules": the striatal spine module. Brain Res Rev 55:55-67. CrossRef Medline
12. Ferré S., Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow N. D, Waldhoer M, Woods AS, Franco R (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5:131-134. CrossRef Medline
13. Franco R., Casadó V, Mallol J, Ferré S, Fuxe K, Cortés A, Ciruela F, Lluis C, Canela E. I (2005) Dimer-based model for heptaspanning membrane receptors. Trends Biochem Sci 30:360-366. CrossRef Medline
14. Franco R., Casadó V, Mallol J, Ferrada C, Ferré S, Fuxe K, Cortés A, Ciruela F, Lluis C., Canela EI (2006) The two-state dimer receptor model: a general model for receptor dimers. Mol Pharmacol 69:1905-1912. CrossRef Medline
15. Gerfen C. R, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441-466. CrossRef Medline
16. González S., Moreno-Delgado D, Moreno E, Pérez-Capote K, Franco R, Mallol J, Cortés A, Casadó V, Lluís C, Ortiz J, Ferré S, Canela E, McCormick PJ (2012) Circadian-related heteromerization of adrenergic and dopamine D4 receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol 10:e1001347. CrossRef Medline
17. Hayashi T., Su T (2005) The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 3:267-280. CrossRef Medline
18. Hiranita T., Soto PL, Tanda G, Katz JL (2010) Reinforcing Effects of σ-Receptor Agonists in Rats Trained to Self-Administer Cocaine. J Pharmacol Exp Ther 332:515-524. CrossRef Medline
19. Hiranita T., Mereu M, Soto PL, Tanda G, Katz JL (2013) Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology 38:605-615. CrossRef Medline
20. Hoffmann H. M, Nadal R, Vignes M, Ortiz J (2012) Chronic cocaine selfadministration modulates ERK1/2 and CREB responses to dopamine receptor agonists in striatal slices. Addict Biol 17:565-575. CrossRef Medline
21. Katz J. L, Su TP, Hiranita T, Hayashi T, Tanda G, Kopajtic T, Tsai SY (2011) A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals 4:880-914. CrossRef Medline
22. Kourrich S., Su TP, Fujimoto M, Bonci A (2012) The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci 35:762-771. CrossRef Medline
23. Kourrich S., Hayashi T, Chuang JY, Tsai SY, Su T-P, Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247. CrossRef Medline
24. Langa F., Codony X, Tovar V, Lavado A, Giménez E, Cozar P, Cantero M, Dordal A., Hernández E, Pérez R, Monroy X, Zamanillo D, Guitart X, Montoliu L. (2003) Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur J Neurosci 18:2188-2196. CrossRef Medline
25. Lepsch L. B, Munhoz CD, Kawamoto EM, Yshii LM, Lima LS, Curi-Boaventura M. F, Salgado TM, Curi R, Planeta CS, Scavone C (2009) Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol Brain 2:3. CrossRef Medline
26. Liu Y., Matsumoto RR (2008) Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies. J Pharmacol Exp Ther 327:187-195. CrossRef Medline
27. Matsumoto R. R, Liu Y, Lerner M, Howard EW, Brackett DJ (2003) Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 469:1-12. CrossRef Medline
28. Maurice T., Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124:195-206. CrossRef Medline
29. Moreno E., Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, Cortés A, Mallol J, Vignes M, McCormick PJ, Canela EI, Lluís C, Moratalla R, Ferré S., Ortiz J, Franco R (2011a) Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286:5846-5854. CrossRef Medline
30. Moreno E., Vaz SH, Caí NS, Ferrada C, Quiroz C, Barodia SK, Kabbani N, Canela E. I, McCormick PJ, Lluis C, Franco R, Ribeiro JA, Sebastião AM, Ferré S. (2011b) Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. J Neurosci 31:7412-7423. CrossRef Medline
31. Nann-Vernotica E, Donny EC, Bigelow GE, Walsh SL (2001) Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155:338-347. CrossRef Medline
32. Navarro G., Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortés A., Casadó V, Canela EI, Ortiz J, Fuxe K, Lluís C, Ferré S, Franco R (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A 107: 18676-18681. CrossRef Medline
33. Navarro G., Moreno E, Bonaventura J, Brugarolas M, Farré D, Aguinaga D, Mallol J., Cortés A, Casadó V, Lluís C, Ferre S, Franco R, Canela E, Mc-Cormick P. J (2013) Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. PLoS One 8:e61245. CrossRef Medline
34. Ortiz De Pablo J, Self DW (2011) Use of H3 histaminergic agonists for the treatment of addiction to drugs of abuse. Accessed June 10, 2013.
35. Panula P., Nuutinen S (2013) The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14:472-487. CrossRef Medline
36. Paoletti P., Vila I, Rifé M, Lizcano JM, Alberch J, Ginés S (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J Neurosci 28:10090-10101. CrossRef Medline
37. Park K., Volkow ND, Pan Y, Du C (2013) Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling. J Neurosci 33:15827-15836. CrossRef Medline
38. Pascoli V., Turiault M, Lüscher C (2012) Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481:71-75. CrossRef Medline
39. Pettit H. O, Pan HT, Parsons LH, Justice JB Jr (1990) Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804. CrossRef Medline
40. Ritz M. C, George FR (1997) Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology 129:311-321. CrossRef Medline
41. Robson M. J, Noorbakhsh B, Seminerio MJ, Matsumoto RR (2012) Sigma-1 receptors: potential targets for the treatment of substance abuse. Curr Pharm Des 18:902-919. CrossRef Medline
42. Shenoy S. K, Lefkowitz RJ (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-515. CrossRef Medline
43. Shenoy S. K, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont R. T, Lichtarge O, Lefkowitz RJ (2006) Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:1261-1273. Medline
44. Söderberg O., Leuchowius KJ, Gullberg M, Jarvius M, Weibrecht I, Larsson LG, Landegren U (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45:227-232. CrossRef Medline
45. Takagi H., Morishima Y, Matsuyama T, Hayashi H, Watanabe T, Wada H (1986) Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker. Brain Res 364:114-123. CrossRef Medline
46. Trifilieff P., Rives ML, Urizar E, Piskorowski RA, Vishwasrao HD, Castrillon J, Schmauss C., Slättman M, Gullberg M, Javitch JA (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques 51:111-118. CrossRef Medline
47. Volkow N. D, Wang GJ, Tomasi D, Baler RD (2013) Unbalanced neuronal circuits in addiction. Curr Opin Neurobiol 23:639-648. CrossRef Medline
48. Weiss F., Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR (2001) Compulsive drug-seeking behavior and relapse. Ann N Y Acad Sci 937:1-26. Medline
49. Williams J. M, Galli A (2006) The dopamine transporter: a vigilant border control for psychostimulant action. Handb Exp Pharmacol 215-232. Medline
50. Wolf M. E, Mangiavacchi S, Sun X (2003) Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann N Y Acad Sci 1003:241-249. CrossRef Medline
51. Xu M., Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994) Elimination of cocaine-induced hyperactivity and dopaminemediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955. CrossRef Medline
52. Zhang D., Zhang L, Tang Y, Zhang Q, Lou D, Sharp FR, Zhang J, XuM (2005) Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30: 1443-1454. CrossRef Medline
53. Zimmermann T., Rietdorf J, Girod A, Georget V, Pepperkok R (2002) Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair. FEBS Lett 531:245-249. CrossRef Medline